NDC 70710-1726

Nelarabine

Nelarabine

Nelarabine is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Zydus Pharmaceuticals (usa) Inc.. The primary component is Nelarabine.

Product ID70710-1726_c413382e-8621-4c5a-940e-61e7a285286f
NDC70710-1726
Product TypeHuman Prescription Drug
Proprietary NameNelarabine
Generic NameNelarabine
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2021-11-17
Marketing CategoryANDA /
Application NumberANDA215037
Labeler NameZydus Pharmaceuticals (USA) Inc.
Substance NameNELARABINE
Active Ingredient Strength5 mg/mL
Pharm ClassesNucleoside Metabolic Inhibitor [EPC],Nucleic Acid Synthesis Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 70710-1726-1

1 VIAL, SINGLE-DOSE in 1 CARTON (70710-1726-1) > 50 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2021-11-17
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Nelarabine" or generic name "Nelarabine"

NDCBrand NameGeneric Name
70710-1726NelarabineNelarabine
70771-1685NelarabineNelarabine
0078-0683Arranonnelarabine

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.